Does sacubitril/valsartan work in children with heart failure?—a pilot study

BackgroundSacubitril/valsartan is an angiotensin receptor neprilysin antagonist (ARNI) approved for adult heart failure (HF). Its safety and efficacy in pediatric HF patients with cardiomyopathy or congenital heart disease are poorly understood. A pilot study was conducted to assess the clinical res...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Yahe Xu, Mingjie Zhang, Yijun Chen, Xi Chen, Wenting Song, Limin Zhu, Liping Liu, Xiaolei Gong, Yuqi Zhang, Zhuoming Xu
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2023-11-01
Serija:	Frontiers in Cardiovascular Medicine
Teme:	sacubitril/valsartan heart failure congenital heart disease cardiomyopathy HFrEF—heart failure with reduced ejection fraction
Online dostop:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1274990/full
Oznake:	Označite Brez oznak, prvi označite!